ClinicalTrials.Veeva

Menu

Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting

A

Azienda Ospedaliera San Giovanni Battista

Status

Completed

Conditions

Hepatitis B Virus
Hematological Malignancies
Allograft

Study type

Observational

Funder types

Other

Identifiers

NCT00876148
LAM Allo SCT

Details and patient eligibility

About

The purpose of this study is to evaluate the risk of hepatitis B reactivation in patients undergoing allografting.

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • All patients undergoing an allograft for hematological malignancies

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems